Beta Bionics to Present at the Bank of America Securities Health Care Conference
Beta Bionics (Nasdaq: BBNX) will present at the Bank of America Securities Health Care Conference in Las Vegas on Tuesday, May 12, 2026 at 2:20 PM ET (11:20 AM PT).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Beta Bionics (Nasdaq: BBNX) will present at the Bank of America Securities Health Care Conference in Las Vegas on Tuesday, May 12, 2026 at 2:20 PM ET (11:20 AM PT).
A live audio webcast will be available on the company’s Investors & Events page at https://investors.betabionics.com and will be archived there for future replay.
Details
News Market Reaction – BBNX
On Apr 28, the first trading day after this news, BBNX closed 5.35% below the previous close.
Data tracked by StockTitan Argus for the Apr 28 session.
Key Figures
- Conference date
- May 12, 2026
- Bank of America Securities Health Care Conference presentation
- Presentation time (ET)
- 2:20 pm
- Scheduled time for conference presentation
- Presentation time (PT)
- 11:20 am
- Pacific Time equivalent for conference presentation
Historical Context
-
Strong Q1 2026 growth and raised full-year revenue and margin guidance.
-
Launch of Bionic Insights to enhance clinical data interpretation for iLet users.
-
Announcement of timing and access details for Q1 2026 results call.
-
Notice of management presentation at the TD Cowen health care conference.
-
Strong 2025 revenue growth, larger installed base, and initial 2026 guidance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
IRVINE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities Health Care Conference in Las Vegas on Tuesday, May 12, 2026 at 2:20 pm Eastern Time (11:20 am Pacific Time).
A live audio webcast of the presentation will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, and will be archived there for future replay following the event.
About Beta Bionics
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit www.betabionics.com.
Investor Relations:
Blake Beber
Head of Investor Relations
ir@betabionics.com
Media and Public Relations:
Felicia Sanborn
Vice President of Marketing
media@betabionics.com
Source: Beta Bionics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.